Back to top

Pharma Mar SA (PHMMF) Receives a Buy from Chardan Capital

Chardan Capital analyst Keay Nakae maintained a Buy rating on Pharma Mar SA yesterday and set a price target of €100.00. Nakae covers the Healthcar...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

PulteGroup, Inc. (PHM)

Pharma Mar (PHMMF)